Traditional Chinese medicine composition for treating hyperglycemia and preparation method thereof

A composition and high blood sugar technology, applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problems of transient hypoglycemia, easy to repeat, etc.

Inactive Publication Date: 2010-08-18
TONGLING WEIXIN INVESTMENT & CONSULTING
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, various drugs currently have various defects, such as only transient hypoglycemia, easy to repeat, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The dosage of streptozotocin is used to induce hyperglycemia similar to NIDDM, and most of clinical patients have hyperglycemia in MDDM. When NIDDM hyperglycemia rats were treated with the traditional Chinese medicine composition of the present invention for 2-3 weeks, the rats returned to normal state, while the hyperglycemia symptoms of the rats in the NIDDM control group still existed and died after a period of time.

Embodiment 2

[0019] Get 8% by weight of Coptidis Rhizoma extract and 7% by weight of Duyiwei extract, 5% by weight of Achyranthes knuckles extract, 8% by weight of Rhizome extract, 6% by weight of Cardamom extract, 9% by weight of pomegranate extract, 5% by weight of white root extract, 3% by weight of cascara extract, 8% by weight of longan extract, and 5% by weight of Eucommia extract with a One or more pharmaceutically acceptable additives are used to prepare the traditional Chinese medicine composition of the present invention.

[0020] Utilize normal, fasting 18h, sugar load (glucose loaded) and streptozotocin-induced hyperglycemia rats detect as can be seen, the Chinese medicine composition of the present invention (200mg / kg oral administration) has the activity of obviously reducing blood sugar . The onset of effect is within 1 / 2 hour, and the effect lasts for more than 5 hours. In rats fasted for 18 hours, the blood glucose drop of the above dose was recorded as 26 mg / dl (n=24), ...

Embodiment 3

[0022] Take 4% by weight of Coptis chinensis extract and 9% by weight of Duyiwei extract, 8% by weight of Achyranthes bidentata extract, 10% by weight of chrysanthemum fruit extract, 5% by weight of cardamom extract, 10% by weight of pomegranate extract, 9% by weight of white root extract, 10% by weight of cascara extract, 8% by weight of longan extract, and 10% by weight of Eucommia extract with a One or more pharmaceutically acceptable additives are used to prepare the traditional Chinese medicine composition of the present invention.

[0023] Oral administration of the composition (200 mg / kg / day) for 2 to 3 weeks has significant curative effect on non-insulin-dependent hyperglycemia, and the curative effect is measured by the following indicators: i) blood sugar level, ii) impact on body weight, iii) Animal survival, iv) water intake, urinary excretion & presence of glucose in urine, v) general symptoms of animals, and vi) ant patronage of rat excreted urine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine composition for treating hyperglycemia and a preparation method thereof. The composition consists of 4 to 10 percent by weight of coptis root extract, 4 percent to 11 percent by weight of lamiophlomis rotate extract, 5 percent to 8 percent by weight of achyranthes bidentata extract, 5 percent to 11 percent by weight of Philippine violet herb, 5 percent to 9 percent by weight of round cardamom extract, 8 percent to 11 percent by weight of pomegranate extract, 4 percent to 9 percent by weight of bletilla extract, 2 percent to 11 percent by weight of cascara extract, 8 percent to 12 percent by weight of long pepper extract, 2 percent to 11 percent by weight of eucommia bark extract and one or more pharmaceutically acceptable additives.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating hyperglycemia and a preparation method thereof. Background technique [0002] Hyperglycemia is a disorder in which blood sugar is measured, either because the body cannot produce enough insulin or because the body's cells do not respond properly to produce insulin. Insulin is a hormone produced by the pancreas that helps the body's cells absorb sugar and break it down for energy. If the body's cells cannot absorb the sugar, it will accumulate in the blood, causing high blood sugar and leading to various potential complications. [0003] As of 2000, there are at least 1.71 million people suffering from hyperglycemia worldwide, or 2.8% of the population suffering from hyperglycemia. Type 1 therapy usually includes a combination of regular or potent insulins, and / or synthetic insulin analogs. However, there are various defects in the various medicines that have at present,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9064A61P3/10
CPCA61K36/67A61K36/86A61K36/46A61K36/898A61K36/718A61K36/53A61K36/21A61K36/9064A61K36/72A61K36/185A61P3/10A61K2300/00
Inventor 张宝宇
Owner TONGLING WEIXIN INVESTMENT & CONSULTING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap